Topic Editors

Discipline of Medical Radiation Science, Curtin Medical School, Curtin University, Perth 6845, Australia
Unità di Cardiologia del Congenito Adulto, Centro di Cardiologia Pediatrica e del Congenito Adulto, IRCCS Policlinico San Donato, San Donato Milanese, Milano Università Vita Salute San Raffaele, Milan, Italy
1. Department of Paediatric Cardiology and Cardiovascular Pathophysiology Unit, Institute of Biomedicine of Seville IBIS, Hospital Virgen Del Rocio, 41013 Seville, Spain
2. Biomedical Engineering & Imaging Sciences, King’s College London, St Thomas Hospital, London SE17EH, UK
Division of Congenital and Structural Cardiology, University Hospitals Leuven, Leuven, Belgium

Usefulness and Clinical Applications of 3D Printing in Cardiovascular Diseases 2.0

Abstract submission deadline
closed (31 March 2023)
Manuscript submission deadline
closed (31 October 2023)
Viewed by
6090

Topic Information

Dear Colleagues,

Given the success of the first edition, we believe it is the time to launch the second edition of this Topic. This second edition of the Topic aims to focus on recent advances in 3D printing and its value or applications in cardiovascular diseases. Three-dimensional printing has evolved rapidly over the last decade, showing great potential in many medical domains, in particular, in the field of cardiovascular disease. Patient-specific or personalized 3D-printed models are shown to enhance our understanding of complex cardiac anatomy and pathology; assist presurgical planning and the simulation of complicated procedures for the treatment of cardiovascular diseases; improve the education of medical students or healthcare professionals; and improve communication between physicians and patients. This issue will highlight the current advances in 3D printing, with special emphasis given to patient-specific 3D-printed models in the diagnosis and management of congenital heart disease and other cardiovascular diseases. Technological developments, including 3D printing materials and bioprinting or tissue engineering, 3D printing integrated with virtual reality and augmented reality, as well as artificial intelligence, are also included in the potential topics of this Topic.

Prof. Dr. Zhonghua Sun
Prof. Dr. Massimo Chessa
Dr. Israel Valverde
Prof. Dr. Alexander Van De Bruaene
Topic Editors

Keywords

  • 3D printing
  • congenital heart disease
  • cardiovascular disease
  • virtual reality
  • augmented reality
  • artificial intelligence
  • bioprinting

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Applied Biosciences
applbiosci
- - 2022 37.7 Days CHF 1000
Bioengineering
bioengineering
4.6 4.2 2014 17.7 Days CHF 2700
Biomolecules
biomolecules
5.5 8.3 2011 16.9 Days CHF 2700
Journal of Cardiovascular Development and Disease
jcdd
2.4 2.4 2014 20.3 Days CHF 2700
Journal of Clinical Medicine
jcm
3.9 5.4 2012 17.9 Days CHF 2600
Micromachines
micromachines
3.4 4.7 2010 16.1 Days CHF 2600
Reports
reports
0.9 - 2018 20.6 Days CHF 1400

Preprints.org is a multidiscipline platform providing preprint service that is dedicated to sharing your research from the start and empowering your research journey.

MDPI Topics is cooperating with Preprints.org and has built a direct connection between MDPI journals and Preprints.org. Authors are encouraged to enjoy the benefits by posting a preprint at Preprints.org prior to publication:

  1. Immediately share your ideas ahead of publication and establish your research priority;
  2. Protect your idea from being stolen with this time-stamped preprint article;
  3. Enhance the exposure and impact of your research;
  4. Receive feedback from your peers in advance;
  5. Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (3 papers)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
8 pages, 1618 KiB  
Case Report
Transapical Mitral Valve-in-Ring Replacement Using the Innovative System under 3-Dimensional Printing Guidance
by Yiwei Wang, Yu Mao, Mengen Zhai, Yanyan Ma, Lanlan Li, Yang Liu and Jian Yang
J. Cardiovasc. Dev. Dis. 2023, 10(8), 339; https://doi.org/10.3390/jcdd10080339 - 07 Aug 2023
Viewed by 1170
Abstract
Background: Transcatheter mitral valve-in-ring replacement (TMViR) is an emerging alternative for patients with recurrent mitral regurgitation (MR) after a prior failed annuloplasty ring. However, intraoperative common issues and complications remain to be addressed. Case summary: We describe the case of a 67-year-old male [...] Read more.
Background: Transcatheter mitral valve-in-ring replacement (TMViR) is an emerging alternative for patients with recurrent mitral regurgitation (MR) after a prior failed annuloplasty ring. However, intraoperative common issues and complications remain to be addressed. Case summary: We describe the case of a 67-year-old male patient who underwent surgical mitral concomitant tricuspid annuloplasty repair 7 years ago who developed recurrent severe MR (New York Heart Association functional class IV). To avoid a high-risk surgical reoperation, we chose to perform a TMViR using an innovative dedicated device—the Mi-thos system—via a transapical approach. A patient-specific, 3-dimensional printed model was used to guide the procedure to avoid potential challenges. The procedure was performed successfully, and the patient exhibited symptomatic improvement. Conclusions: This case report highlights the first use of the innovative Mi-thos system in a TMViR procedure. The findings demonstrate the feasibility and safety of utilizing the Mi-thos system, guided by 3-dimensional printing technology, for patients who have experienced recurrent mitral regurgitation MR following a failed annuloplasty ring. Full article
Show Figures

Figure 1

29 pages, 6940 KiB  
Review
Three-Dimensional Bioprinting in Cardiovascular Disease: Current Status and Future Directions
by Zhonghua Sun, Jack Zhao, Emily Leung, Maria Flandes-Iparraguirre, Michael Vernon, Jenna Silberstein, Elena M. De-Juan-Pardo and Shirley Jansen
Biomolecules 2023, 13(8), 1180; https://doi.org/10.3390/biom13081180 - 28 Jul 2023
Cited by 5 | Viewed by 2473
Abstract
Three-dimensional (3D) printing plays an important role in cardiovascular disease through the use of personalised models that replicate the normal anatomy and its pathology with high accuracy and reliability. While 3D printed heart and vascular models have been shown to improve medical education, [...] Read more.
Three-dimensional (3D) printing plays an important role in cardiovascular disease through the use of personalised models that replicate the normal anatomy and its pathology with high accuracy and reliability. While 3D printed heart and vascular models have been shown to improve medical education, preoperative planning and simulation of cardiac procedures, as well as to enhance communication with patients, 3D bioprinting represents a potential advancement of 3D printing technology by allowing the printing of cellular or biological components, functional tissues and organs that can be used in a variety of applications in cardiovascular disease. Recent advances in bioprinting technology have shown the ability to support vascularisation of large-scale constructs with enhanced biocompatibility and structural stability, thus creating opportunities to replace damaged tissues or organs. In this review, we provide an overview of the use of 3D bioprinting in cardiovascular disease with a focus on technologies and applications in cardiac tissues, vascular constructs and grafts, heart valves and myocardium. Limitations and future research directions are highlighted. Full article
Show Figures

Figure 1

14 pages, 5002 KiB  
Article
Clinical Applications of Mixed Reality and 3D Printing in Congenital Heart Disease
by Ivan Lau, Ashu Gupta, Abdul Ihdayhid and Zhonghua Sun
Biomolecules 2022, 12(11), 1548; https://doi.org/10.3390/biom12111548 - 24 Oct 2022
Cited by 7 | Viewed by 1882
Abstract
Understanding the anatomical features and generation of realistic three-dimensional (3D) visualization of congenital heart disease (CHD) is always challenging due to the complexity and wide spectrum of CHD. Emerging technologies, including 3D printing and mixed reality (MR), have the potential to overcome these [...] Read more.
Understanding the anatomical features and generation of realistic three-dimensional (3D) visualization of congenital heart disease (CHD) is always challenging due to the complexity and wide spectrum of CHD. Emerging technologies, including 3D printing and mixed reality (MR), have the potential to overcome these limitations based on 2D and 3D reconstructions of the standard DICOM (Digital Imaging and Communications in Medicine) images. However, very little research has been conducted with regard to the clinical value of these two novel technologies in CHD. This study aims to investigate the usefulness and clinical value of MR and 3D printing in assisting diagnosis, medical education, pre-operative planning, and intraoperative guidance of CHD surgeries through evaluations from a group of cardiac specialists and physicians. Two cardiac computed tomography angiography scans that demonstrate CHD of different complexities (atrial septal defect and double outlet right ventricle) were selected and converted into 3D-printed heart models (3DPHM) and MR models. Thirty-four cardiac specialists and physicians were recruited. The results showed that the MR models were ranked as the best modality amongst the three, and were significantly better than DICOM images in demonstrating complex CHD lesions (mean difference (MD) = 0.76, p = 0.01), in enhancing depth perception (MD = 1.09, p = 0.00), in portraying spatial relationship between cardiac structures (MD = 1.15, p = 0.00), as a learning tool of the pathology (MD = 0.91, p = 0.00), and in facilitating pre-operative planning (MD = 0.87, p = 0.02). The 3DPHM were ranked as the best modality and significantly better than DICOM images in facilitating communication with patients (MD = 0.99, p = 0.00). In conclusion, both MR models and 3DPHM have their own strengths in different aspects, and they are superior to standard DICOM images in the visualization and management of CHD. Full article
Show Figures

Figure 1

Back to TopTop